Stilbene Treatment Reduces Stemness Features in Human Lung Adenocarcinoma Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910390 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Vittoria Livraghi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Immunology and General Pathology Unit, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Stilbenes, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MUR), Department of Molecular Medicine of the University of Pavia under the initiative ‘Dipartimenti di Eccellenza (2023–2027)’.
Abstract (Originalsprache)
Lung cancer is among the most clinically challenging tumors because of its aggressive proliferation, metastasis, and the presence of cancer stem cells (CSCs). Natural bioactive substances have been used for cancer prevention, and, in particular, resveratrol (RSV), a stilbene-based compound with wide biological properties, has been proposed for chemoprevention. Its lesser-known analogue 4,4’-dihydroxy-trans-stilbene (DHS) has demonstrated superior activity both in cell-based assays and in mouse and zebrafish in vivo models. The present study analyzed the effects of DHS and RSV on A549 lung cancer cells, with a particular focus on stemness features and CSCs, isolated by sorting of the side population (SP). The results show that both stilbenes, especially DHS, strongly inhibited cell cycle progression. A reduction in the S phase was induced by DHS, whereas an increase in this phase was obtained with RSV. In addition, 50% reductions in the clonogenicity and soft agar colony formation were observed with the DHS treatment only. Finally, both stilbenes, especially DHS, reduced stemness marker expression in A549 cells and their sorted SP fraction. Spheroid formation, higher in SP cells than in the main population (MP), was significantly reduced after pretreatment with DHS, which was found to decrease SOX2 levels more than RSV. These findings indicate that stilbenes, and particularly DHS, affect stemness features of A549 cells and the SP fraction, suggesting their potential utility as anticancer agents, either alone or combined with chemotherapeutic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Immunology and General Pathology Unit, University of Pavia, 27100 Pavia, Italy.
- Centro Grandi Strumenti (CGS), University of Pavia, 27100 Pavia, Italy.
ORCID-Profile: Vittoria Livraghi, Lucia Anna Stivala
Förderung
- Italian Ministry of University and Research (MUR)
- Department of Molecular Medicine of the University of Pavia under the initiative ‘Dipartimenti di Eccellenza (2023–2027)’
Zitieren
APA
Livraghi, V., Grossi, A., Scopelliti, A., Senise, G., Gamboa, L. A., Solito, S., Stivala, L. A., Sottile, V., & Savio, M. (2024). Stilbene Treatment Reduces Stemness Features in Human Lung Adenocarcinoma Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910390
Vancouver
Livraghi V, Grossi A, Scopelliti A, Senise G, Gamboa LA, Solito S, et al. Stilbene Treatment Reduces Stemness Features in Human Lung Adenocarcinoma Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910390
BibTeX
@article{Livraghi2024,
author = {Livraghi, Vittoria and Grossi, Alice and Scopelliti, Anna and Senise, Giorgia and Gamboa, Luciano Augusto and Solito, Samantha and Stivala, Lucia Anna and Sottile, Virginie and Savio, Monica},
title = {Stilbene Treatment Reduces Stemness Features in Human Lung Adenocarcinoma Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910390}
}
EUVIMED